Showing 10,101 - 10,120 results of 18,433 for search 'significant ((((step decrease) OR (((we decrease) OR (a decrease))))) OR (mean decrease))', query time: 0.51s Refine Results
  1. 10101

    Flow diagram. by Barbara Mayr (7065950)

    Published 2024
    “…We found a significant increase both times for miR-103a (glycolysis, %change base: +12%, post +17%), miR-146a (inflammation, %change base: +20%, post +21%), and miR-222 (cardiac remodeling, %change base: +10%, post +21%), while miR-30a (inflammation, %change base: -27%, post: -38%) decreased significantly (all p≤0.043).…”
  2. 10102

    Data Sheet 1_Comparison of intravascular imaging, physiological assessment and angiography for coronary revascularization in acute coronary syndrome: a systematic review and networ... by Xuan-Yan Liu (19362096)

    Published 2025
    “…The research unveiled no statistically significant differences between FFR-guided culprit-only PCIs and culprit-only PCIs or angiography-guided CR.…”
  3. 10103

    Table1_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx by Qiong Jie (13270095)

    Published 2024
    “…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
  4. 10104

    Image2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.TIF by Qiong Jie (13270095)

    Published 2024
    “…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
  5. 10105

    Table2_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.docx by Qiong Jie (13270095)

    Published 2024
    “…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
  6. 10106

    Image1_Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system.TIF by Qiong Jie (13270095)

    Published 2024
    “…The risk of AEs such as decreased platelet count, anemia, decreased white blood cell count, pneumonitis, asthenia, and edema caused by pralsetinib is significantly higher than that of selpercatinib. …”
  7. 10107

    Proteomic and Lipidomic Plasma Evaluations Reveal Biomarkers for Domoic Acid Toxicosis in California Sea Lions by Amie M. Solosky (20320255)

    Published 2024
    “…Domoic acid is a neurotoxin secreted by the marine diatom genus <i>Pseudo-nitzschia</i> during toxic algal bloom events. …”
  8. 10108

    Proteomic and Lipidomic Plasma Evaluations Reveal Biomarkers for Domoic Acid Toxicosis in California Sea Lions by Amie M. Solosky (20320255)

    Published 2024
    “…Domoic acid is a neurotoxin secreted by the marine diatom genus <i>Pseudo-nitzschia</i> during toxic algal bloom events. …”
  9. 10109

    Efficacy and safety of trastuzumab deruxtecan in HER2-high and HER2-low breast cancer: a systematic review and meta-analysis of randomized controlled trials by Sheng-Yen Hsiao (9939006)

    Published 2025
    “…This meta-analysis assessed four randomized controlled trials (DESTINY-Breast02, −03, −04, and −06; 2555 patients) from PubMed, Embase, Cochrane Library, and ClinicalTrials.gov. A random-effects model revealed that T-DXd significantly improved progression-free survival (hazard ratio [HR] = 0.433; 95% confidence interval [CI]: 0.305–0.616; P < 0.001; <i>I<sup>2</sup></i> = 90.7%) and overall survival (HR = 0.720; 95% CI: 0.636–0.816; P < 0.001; <i>I<sup>2</sup></i> = 0%) versus control regimens, with consistent benefits across HER2 subgroups. …”
  10. 10110

    Image2_Overexpression of vacuolar H+-pyrophosphatase from a recretohalophyte Reaumuria trigyna enhances vegetative growth and salt tolerance in transgenic Arabidopsis thaliana.tif by Ningning Li (566420)

    Published 2024
    “…Catalase enzyme activity, proline content, relative water content, and soluble sugar content were significantly increased in transgenic Arabidopsis under salt stresses, but the malondialdehyde content was dramatically decreased. …”
  11. 10111

    Image1_Overexpression of vacuolar H+-pyrophosphatase from a recretohalophyte Reaumuria trigyna enhances vegetative growth and salt tolerance in transgenic Arabidopsis thaliana.tif by Ningning Li (566420)

    Published 2024
    “…Catalase enzyme activity, proline content, relative water content, and soluble sugar content were significantly increased in transgenic Arabidopsis under salt stresses, but the malondialdehyde content was dramatically decreased. …”
  12. 10112

    Table1_Overexpression of vacuolar H+-pyrophosphatase from a recretohalophyte Reaumuria trigyna enhances vegetative growth and salt tolerance in transgenic Arabidopsis thaliana.doc by Ningning Li (566420)

    Published 2024
    “…Catalase enzyme activity, proline content, relative water content, and soluble sugar content were significantly increased in transgenic Arabidopsis under salt stresses, but the malondialdehyde content was dramatically decreased. …”
  13. 10113

    Table 1_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  14. 10114

    Table 3_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  15. 10115

    Table 2_Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial.docx by Xinhui Yang (12051251)

    Published 2025
    “…Intragroup analysis indicated a significant decrease in TMAO levels at 6 months compared with baseline (adjusted p<0.05). …”
  16. 10116
  17. 10117

    Table 1_The relationship between positive future thinking, entrapment, defeat and death-related mental imagery in individuals with and without a suicidal history: an experimental s... by Gonca Köse (21477470)

    Published 2025
    “…Mean scores for PFT from pre-to post-negative mood induction decreased significantly in the participants with a history of suicidal thoughts/behaviours but not in those without a suicidal history. …”
  18. 10118

    Changes of wind direction, wind speed and specific <i>orf2</i> amplicons during typhoon events for a range of years (2019–2020, n by Kuang-Yueh Chen (21071954)

    Published 2025
    “…Shades of blue, from dark (6-8 m/sec, largest) to light (0-2 m/sec, smallest), divided into 4 intervals, represent decreasing average wind speeds per hour (A). Comparison of aerosol concentrations (median values) between the north and south sides of the hills is illustrated (B, left), and the comparison of average northwesterly wind speeds per hours (median values) between the same regions, during typhoon landing, is illustrated (B, right). …”
  19. 10119

    Supplementary file 1_Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial.docx by Xi Zhang (83736)

    Published 2025
    “…</p>Conclusion<p>Daily administration of YLGB-1496 at a dosage of 1.5 × 10<sup>10</sup> CFU for 3 months significantly reduced the episodes of cough, fever, dry stool (defined as Bristol stool scale type 1–3), and eczematous changes of the skin. …”
  20. 10120

    Table1_Asparagus officinalis L. extract exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells and a transgenic mouse model of endometrial cancer.pdf by Ziwei Fang (10115899)

    Published 2024
    “…Asparagus officinalis extract treatment for 4 weeks resulted in a significant reduction in tumor growth in Lkb1<sup>fl/fl</sup>p53<sup>fl/fl</sup> mice under both obese and lean conditions, with a decrease in Ki-67 and vascular endothelial growth factor expression and an increase in Bip expression in endometrial tumors.…”